 NAPLES, Fla., Nov. 29, 2021 PRNewswire - Enveric Biosciences NASDAQ: ENVB Enveric or the Company, a patient-centric biotechnology company developing next-generation mental health and oncology treatments by leveraging psychedelic-derived molecules for the mind and synthetic cannabinoids for the body, today announced that Dr. Joseph Tucker, Chief Executive Officer of Enveric Biosciences, will participate in the H.C. 